-
20-HETE–TRPV1 Signaling and Sensory Neuron Plasticity in Der
2026-06-22
This study reveals that the metabolite 20-HETE drives chronic itch in dermatitis by activating TRPV1 channels on MrgprA3+ sensory neurons. These findings clarify sensory cross-talk mechanisms and highlight novel molecular targets for chronic itch interventions.
-
N-octanoyl-L-Homoserine Lactone: Applied Workflows in Infect
2026-06-22
N-octanoyl-L-Homoserine lactone (C8-HSL) is revolutionizing microbial pathogenicity research by enabling precise control of quorum sensing and host–microbe interaction models. This article translates the latest experimental evidence and workflow advances into practical guidance for optimizing biofilm, virulence, and translational cancer assays.
-
Erastin as a Precision Ferroptosis Inducer: Mechanisms, Assa
2026-06-21
Explore how Erastin, a leading ferroptosis inducer, enables precision cancer biology research through advanced mechanistic understanding and optimized assay protocols. This article uniquely integrates the latest evidence on ferroptosis resistance for practical experimental design.
-
Surfactant-Derived LNPs Enable Efficient mRNA Delivery to Ma
2026-06-20
This study introduces dual-component lipid nanoparticles (LNPs) based on surfactant-derived ionizable lipids for efficient intracellular delivery of mRNA to macrophages. The platform bypasses PEGylation, achieves nuclease resistance, and demonstrates high delivery efficiency, representing a notable advance for hard-to-transfect immune cells.
-
AT13387: Precision Hsp90 Inhibitor for Advanced Cancer Biolo
2026-06-19
AT13387, a next-generation Hsp90 inhibitor, empowers researchers with nanomolar potency and exceptional tumor retention for dissecting oncogenic signaling and apoptosis. This guide delivers actionable workflows, troubleshooting strategies, and reference-driven insights to maximize impact in cancer biology research.
-
Cell-Specific Uptake of PEGylated Iron Oxide Nanoparticles i
2026-06-19
This study elucidates how size and PEGylation of iron oxide nanoparticles govern their cell-type-specific uptake in the liver, challenging long-standing assumptions about clearance pathways. Insights from in vivo and primary liver cell models inform safer nanomedicine design with improved targeting and reduced hepatic accumulation.
-
WEHI-539: Applied BCL-XL Inhibitor Workflows in Apoptosis Re
2026-06-18
WEHI-539 enables precise, selective targeting of BCL-XL for dissecting apoptosis resistance and optimizing cancer stem cell sensitization assays. This guide delivers actionable workflows, troubleshooting, and key translational insights from recent glioblastoma studies to maximize your experimental impact.
-
Alpha-MSH Amide: Molecular Insights into Pigmentation and In
2026-06-18
Explore the molecular mechanisms of a-MSH, amide in pigmentation regulation and inflammation. This article offers an advanced analysis of alpha-melanocyte-stimulating hormone amide, its receptor signaling, and unique research applications, setting it apart from protocol-focused resources.
-
RSL3-Induced PARP1 Modulation: Dual Apoptotic Pathways Durin
2026-06-17
Chen et al. (2025) elucidate how RSL3, a ferroptosis inducer, engages two distinct mechanisms to promote PARP1-mediated apoptosis in cancer cells, even in the context of PARP inhibitor resistance. Their findings clarify the intersection of ferroptosis and apoptosis, revealing translational opportunities for targeting therapy-resistant tumors.
-
CPI-613: Decoding Mitochondrial Metabolism and Cell Fate in
2026-06-17
Explore how CPI-613, a pioneering mitochondrial metabolism inhibitor, advances cancer research by unraveling the interplay between mitochondrial enzymes, calcium signaling, and cell death regulation. This article offers a unique, evidence-based perspective on CPI-613’s role in apoptosis and tumor cell metabolism studies.
-
Translational mRNA Rescue: From Mechanism to Workflow Master
2026-06-16
This thought-leadership article explores how advances in in vitro transcription technologies, exemplified by the HyperScribe™ T7 High Yield RNA Synthesis Kit Plus, are empowering translational researchers to design and validate mRNA-based interventions. Using recent breakthroughs in Birt-Hogg-Dubé syndrome genetics as a case study, we connect mechanistic insight with strategic lab guidance, highlighting competitive differentiators and offering an evidence-linked protocol framework for high-yield, high-fidelity RNA synthesis.
-
Anlotinib hydrochloride: Reliable Multi-Target TKI for Cance
2026-06-16
This article provides a scenario-driven exploration of how Anlotinib hydrochloride (SKU C8688) addresses reproducibility, sensitivity, and practical challenges in angiogenesis and proliferation assays. Drawing on peer-reviewed evidence and APExBIO's product dossier, it guides biomedical researchers and lab technicians in optimizing workflows and interpreting data using this potent multi-target tyrosine kinase inhibitor.
-
Ridaforolimus (Deforolimus): Applied mTOR Inhibition Workflo
2026-06-15
Ridaforolimus (Deforolimus, MK-8669) empowers cancer and senescence researchers with unparalleled nanomolar mTOR inhibition, enabling precise control over cell proliferation and angiogenesis. This article delivers a hands-on guide to optimized protocols, troubleshooting, and integration with modern AI-driven senolytic discovery.
-
Lipo3K Transfection Reagent: High-Efficiency Workflows Unloc
2026-06-15
Lipo3K Transfection Reagent revolutionizes nucleic acid delivery, particularly in challenging cell types, with high efficiency and minimal toxicity. Discover workflow enhancements, troubleshooting, and real-world applications that position Lipo3K as a superior choice for gene expression and RNA interference studies.
-
D-Luciferin (Potassium Salt): Precision Tools for Real-Time
2026-06-14
Explore how D-Luciferin (potassium salt) enables high-precision, real-time in vivo tumor imaging and advanced bioluminescence assays. This article provides a unique, assay-focused perspective on maximizing sensitivity and reproducibility in preclinical oncology research.